The hits just keep on coming when it comes to the health benefits of meditation. Research is now emerging that would justify implementing this practice within hospitals and schools (some already do) as well as including it in treatment recommendations for various diseases.
Not long ago, an eight week study conducted by Harvard researchers at Massachusetts General Hospital (MGH) determined that meditation literally rebuilds the brains grey matter in just eight weeks. It was the very first study to document that meditation produces changes over time in the brain’s grey matter. Now, they’ve released another study showing that meditation can have a significant impact on clinical symptoms of gastrointestinal disorders, irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). The study showed that elicitation of the relaxation response (a physical state of deep rest that changes the physical and emotional responses to stress) is a very big help.
The study comes out of the Benson-Henry Institute for Mind Body Medicine at Massachusetts General Hospital (MGH) and Beth Israel Deaconess Medical Center (BIDMC). This is the very first study where the use of the “relaxation response” was examined in these disorders, and the first to investigate the genomic effects of the relaxation response in individuals with any disorder. The report was published in the journal PLOS-ONE. (source)
Given the two studies cited above, and all of the other documented health benefits of meditation, this should open the door for more studies to examine the benefits of meditation for a wide range of diseases.
“Our results suggest exciting possibilities for further developing and implementing this treatment in a wider group of patients with gastrointestinal illness. Several studies have found that stress management techniques and other psychological interventions can help patients with IBS, at least in the short term; and while the evidence for IBD is less apparent, some studies have suggested potential benefits. What is novel about our study is demonstration of the impact of a mind/body intervention on the genes controlling inflammatory factors that are known to play a major role in IBD and possibly in IBS.” – Brandon Kuo of the gastrointestinal unit in the MGH Department of Medicine, co-lead author of the report. (source)
(Click on the image, above, to read the entire article.)